RDHL
Redhill Biopharma
RDHL
RDHL
8 hedge funds and large institutions have $11.9M invested in Redhill Biopharma in 2014 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$5K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $7.98M | 605,800 | – | – |
|
|
BC
2
Broadfin Capital
New York
| $3.47M | 263,160 | – | – |
|
3
Goldman Sachs
New York
| $382K | 29,000 | – | – |
|
|
MMG
4
Monetary Management Group
St Louis,
Missouri
| $58K | 4,400 | – | – |
|
5
Wells Fargo
San Francisco,
California
| $40K | 3,000 | – | – |
|
6
Bank of America
Charlotte,
North Carolina
| $13K | 1,000 | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $5K | 353 | -574 | -62% |
|
8
Morgan Stanley
New York
| $0 | 4 | – | – |
|